HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,150 | -56.2% | 10,535 | -54.3% | 0.04% | -57.3% |
| Q4 2022 | $2,623 | -100.0% | 23,052 | -79.6% | 0.10% | -65.3% |
| Q3 2022 | $6,998,000 | -39.8% | 113,091 | -22.4% | 0.30% | -36.3% |
| Q2 2022 | $11,627,000 | -23.2% | 145,768 | +1.3% | 0.47% | -7.5% |
| Q1 2022 | $15,138,000 | +8.0% | 143,883 | +10.6% | 0.50% | +23.5% |
| Q4 2021 | $14,020,000 | -2.4% | 130,105 | -0.8% | 0.41% | -8.7% |
| Q3 2021 | $14,366,000 | +13.3% | 131,153 | -3.1% | 0.45% | +20.2% |
| Q2 2021 | $12,680,000 | +7.0% | 135,414 | +5.2% | 0.37% | +4.8% |
| Q1 2021 | $11,850,000 | +21.9% | 128,742 | -3.1% | 0.36% | +14.5% |
| Q4 2020 | $9,719,000 | -10.3% | 132,858 | -4.7% | 0.31% | -21.9% |
| Q3 2020 | $10,830,000 | +6.9% | 139,412 | -23.5% | 0.40% | +1.5% |
| Q2 2020 | $10,128,000 | +62.9% | 182,220 | -13.2% | 0.39% | +34.4% |
| Q1 2020 | $6,219,000 | +17.5% | 209,949 | +43.6% | 0.29% | +66.3% |
| Q4 2019 | $5,293,000 | -16.9% | 146,228 | -37.5% | 0.18% | -17.8% |
| Q3 2019 | $6,370,000 | +58.5% | 233,920 | +40.0% | 0.21% | +62.6% |
| Q2 2019 | $4,019,000 | – | 167,042 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |